Your browser doesn't support javascript.
loading
Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin Lymphoma: An Open-Label Phase I Trial.
Wang, Chun-Meng; Wu, Zhi-Qiang; Wang, Yao; Guo, Ye-Lei; Dai, Han-Ren; Wang, Xiao-Hui; Li, Xiang; Zhang, Ya-Jing; Zhang, Wen-Ying; Chen, Mei-Xia; Zhang, Yan; Feng, Kai-Chao; Liu, Yang; Li, Su-Xia; Yang, Qing-Ming; Han, Wei-Dong.
Afiliação
  • Wang CM; Department of Bio-therapeutic, Chinese PLA General Hospital, Beijing, China.
  • Wu ZQ; Department of Molecular Biology, Institute of Basic Medicine, School of Life Sciences, Chinese PLA General Hospital, Beijing, China.
  • Wang Y; Department of Immunology, Institute of Basic Medicine, School of Life Sciences, Chinese PLA General Hospital, Beijing, China.
  • Guo YL; Department of Immunology, Institute of Basic Medicine, School of Life Sciences, Chinese PLA General Hospital, Beijing, China.
  • Dai HR; Department of Immunology, Institute of Basic Medicine, School of Life Sciences, Chinese PLA General Hospital, Beijing, China.
  • Wang XH; Department of Molecular Biology, Institute of Basic Medicine, School of Life Sciences, Chinese PLA General Hospital, Beijing, China.
  • Li X; Department of Molecular Biology, Institute of Basic Medicine, School of Life Sciences, Chinese PLA General Hospital, Beijing, China.
  • Zhang YJ; Department of Bio-therapeutic, Chinese PLA General Hospital, Beijing, China.
  • Zhang WY; Department of Bio-therapeutic, Chinese PLA General Hospital, Beijing, China.
  • Chen MX; Department of Bio-therapeutic, Chinese PLA General Hospital, Beijing, China.
  • Zhang Y; Department of Bio-therapeutic, Chinese PLA General Hospital, Beijing, China.
  • Feng KC; Department of Bio-therapeutic, Chinese PLA General Hospital, Beijing, China.
  • Liu Y; Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing, China.
  • Li SX; Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing, China.
  • Yang QM; Department of Bio-therapeutic, Chinese PLA General Hospital, Beijing, China.
  • Han WD; Department of Immunology, Institute of Basic Medicine, School of Life Sciences, Chinese PLA General Hospital, Beijing, China. hanwdrsw69@yahoo.com.
Clin Cancer Res ; 23(5): 1156-1166, 2017 Mar 01.
Article em En | MEDLINE | ID: mdl-27582488
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Antígeno Ki-1 / Terapia Baseada em Transplante de Células e Tecidos / Recidiva Local de Neoplasia Tipo de estudo: Guideline Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Antígeno Ki-1 / Terapia Baseada em Transplante de Células e Tecidos / Recidiva Local de Neoplasia Tipo de estudo: Guideline Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos